A 500 mg brand name does not tell a distributor enough to approve an antibiotic for a franchise catalogue. You need to confirm the generic composition, prescribing boundaries, pack documentation, supply controls, and commercial fit before adding it to your range.
Key takeaways
- Match azithromycin 500 mg across the carton, insert and licence documents.
- Check allergies, liver risks, interactions and warning symptoms before listing.
- Record the batch number, expiry date, manufacturer and storage details.
- Compare antibiotic options by evidence, demand, supply reliability and stewardship support.
Confirm the composition, indication and correct regimen before listing Azishot-500
A brand name does not prove what a tablet contains. Before listing pcd pharma franchise azishot 500 tablets, match the carton, package insert, manufacturing licence and batch certificate. Each document should identify azithromycin 500 mg, an immediate-release tablet, the manufacturer, and the marketer; resolve any mismatch before accepting the product.
Azithromycin is the generic name and a macrolide antibacterial. The 500 mg strength does not establish the dose, maximum daily dose or treatment length. A prescriber selects these by infection, age, weight, kidney or liver status, and other medicines.
| Example regimen | What it means | Important limit |
|---|---|---|
| 500 mg once daily for 3 days | A labelled regimen for selected infections | Not suitable for every infection |
| 500 mg on day 1, then 250 mg on days 2 through 5 | A different labelled regimen | A 500 mg tablet is not automatically a three-day course |
Take an immediate-release tablet with or without food only when the approved local insert permits it. Do not copy tablet directions to azithromycin extended-release suspension; that formulation has different administration instructions. The listing must identify prescription status and must not call Azishot-500 a universal treatment for fever, colds, influenza, unexplained fever or every sore throat.
Match supply to the diagnosed infection and approved local label, because a viral illness or an infection needing another antibiotic makes this product the wrong choice.
Screen contraindications, interactions and warning symptoms
Before listing Azishot-500, confirm that the pack contains azithromycin, a macrolide antibacterial. Refer anyone with a macrolide allergy, previous antibiotic-associated diarrhoea, liver disease, or myasthenia gravis to a prescriber or pharmacist before supply.
Seek clinical review for known prolonged QT interval, bradyarrhythmia, previous torsades de pointes, uncompensated heart failure, or low potassium or magnesium. Check these medicines and the actual package insert before dispensing:
- Warfarin or digoxin
- Aluminium- or magnesium-containing antacids
- Antiarrhythmics
- Other medicines that prolong the QT interval
Interaction and antacid instructions vary by formulation, so do not replace the supplied insert with a generic “safe with all medicines” statement.
Nausea, diarrhoea, abdominal pain and rash are recognised effects. Fainting or palpitations require urgent assessment for a rhythm problem; jaundice or dark urine may indicate liver injury; severe watery or bloody diarrhoea may indicate serious antibiotic-associated colitis.
After a missed dose, take it when remembered unless the next dose is near; never double the dose. An accidental extra dose needs medical advice, especially after vomiting, dizziness, fainting or palpitations. Patients must complete the prescribed course unless a clinician changes it, and must not share leftover tablets.
A distributor supplies accurate information, traceability and the current package insert—not a diagnosis or self-treatment plan.
Use the physical pack and records to verify every batch
Accept stock only after matching the physical pack to its records for every batch. An azishot 500 tablet distributor should not rely on a catalogue image or brand name.
1. Read the carton and strip. Confirm printed Azishot-500 brand name, azithromycin 500 mg composition, immediate-release tablet dosage form, film coating, pack quantity, batch number, manufacturing date, expiry date, manufacturing licence number, manufacturer address, marketer details, printed MRP where applicable, intact seal, prescription status, and QR or verification code where present.
2. Match those details with the invoice, certificate of analysis or batch-release document, package insert, and licence records. Confirm the strip or box size, manufacturing site, and stated storage temperature from the supplied pack, not catalogue assumptions.
3. Record receipt date and remaining shelf life against your expiry-at-dispatch rule. Reject or quarantine packs with broken seals, dampness, crushed cartons, illegible printing, mismatched batch details, or missing documents.
4. Store the stock exactly as labelled. If the pack states controlled room temperature, protect it from excessive heat and moisture; do not leave cartons in hot vehicles or damp stockrooms. Check separately whether a supplied suspension or other form has different storage instructions.
5. Rotate stock by earliest expiry, keep invoice and batch traceability, and document complaints with product, batch, defect, photographs, and outcome. Do not supply expired antibiotics; segregate them and use an authorised pharmaceutical-waste route.
A franchise agreement does not replace your distributor licence, invoice records, or state drug-control duties. Verify QR codes through the stated channel and retain the verification result.
Compare Azishot-500 with competing PCD range options
Choose Azishot-500 only if the verified pack fills a catalogue gap rather than adding another azithromycin brand. An azishot 500 tablet distributor should compare documents and operating terms, not rely on a brand name in a large pcd pharma franchise products catalogue.
| Check | Azishot-500 to confirm | Competing option to compare |
|---|---|---|
| Composition | Azithromycin 500 mg on carton, insert, licence and batch certificate | Different molecule or unconfirmed composition |
| Dosage form | Immediate-release tablet, not extended-release suspension | Tablet, capsule, suspension or dispersible form |
| Strength options | 500 mg only, or documented additional strengths | One strength or a complete strength range |
| Pack size | Quantity printed on the actual pack | Quantity and invoice consistency |
| Demand and indications | Prescription demand and approved respiratory, ENT or other indications | Local prescribing need and approved uses |
| Territory terms | Exclusivity, minimum order quantity and expiry at dispatch | Written territory protection and lower expiry exposure |
| Commercial support | Return policy, price sheet, promotion and education materials | Clearer support with less promotional risk |
The range should complement respiratory, ENT, dermatology and paediatric products without duplicating azithromycin across brands or encouraging antibiotic demand. Multiple strengths increase inventory and forecasting work; slow movement creates expiry risk. Add pharmacist and doctor education, storage audits, documentation time and complaint logging to the real cost.
Trulip Pharma is useful at this decision point only if it supplies a current product list, batch documents, delivery lead time, invoice, complaint route and pharmacovigilance contact. Treat the supplier as a traceable source, not prescribing authority.
Related product
 | Azishot-500 Tablets by Trulip Pharma are a broad-spectrum antibiotic formulation used to treat a variety of bacterial infections. View product → |
Build antibiotic stewardship into the franchise sales process
Add Azishot-500 to pcd franchise antibiotic products only with prescription controls. Sale must follow the current Drugs and Cosmetics Rules, state drug-control requirements and the product’s approved Indian labelling. A franchise agreement does not replace the distributor’s licence or supply obligations.
1. Verify the buyer’s and seller’s drug licences, pharmacist credentials and legally permitted supply channel. Obtain the current product list, price sheet, approved label, package insert and regulatory documents.
2. Promote the product for prescription use, not self-medication. Do not claim that azithromycin treats every infection, fever, sore throat or cough. Avoid routine promotion for viral colds, influenza and uncomplicated acute bronchitis; macrolides are also not recommended empirically for some bacterial sinusitis settings because of resistance.
3. Require medical review before any repeat sale. Never encourage shortened courses, leftover-tablet use or patient sharing. Supply information about the approved indication, dose, route and duration, not a diagnosis or substitute regimen.
4. At receipt, record each batch number and expiry date, forecast demand, store stock as the label directs, and rotate earlier-expiry packs first. Log adverse-event complaints, suspected quality defects and treatment failures, then escalate them through the supplied pharmacovigilance channel.
5. Apply a go/no-go test: list Azishot-500 only when its composition, regulatory documents, supply terms, demand forecast and stewardship safeguards are documented. If one is missing, hold the listing.
Frequently asked questions
What documents should you check before listing Azishot-500?
Match the carton, package insert, manufacturing licence and batch certificate. Each should identify azithromycin 500 mg, the tablet type, manufacturer and marketer.
Which safety checks matter before supplying Azishot-500?
Screen for macrolide allergy, liver disease, QT-prolonging medicines and serious warning symptoms such as fainting, severe diarrhoea or jaundice.
How can you verify each Azishot-500 batch?
Inspect the seal, batch number, manufacturing and expiry dates, licence details, storage instructions and physical condition, then record the check.
How should you compare Azishot-500 with other PCD antibiotic products?
Compare the active ingredient, dosage form, approved indications, documentation, supply reliability, demand and the support provided for responsible antibiotic use.
Keywords
